News & Trends - MedTech & Diagnostics
Medtronic’s ‘X factor’ robotics for back pain
Lindy Telford suffered chronic back pain for a decade, but an Australian-first robotic procedure has given her freedom of movement again.
Gold Coast’s Pindara Private Hospital provided the solution after investing in a cutting-edge, million-dollar system.
Using Medtronic’s Mazor X Stealth Edition Robot, surgeons Associate Professor Matthew Scott-Young and Assistant Professor Laurence McEntee put more than 20 metal implants into her spine.
“I was pretty nervous leading up to the surgery but I had a 55-degree curve in my spine that was likely to get worse by about one degree every year,” Ms Telford said.
Surgeons usually rely on ‘freehand’ techniques and x-rays to place screws and rods in complex spine surgery, but A/Prof Scott-Young said the robotic equipment helped to pinpoint the exact placement and trajectory of the implants.
Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
“The Mazor X system tracks the position of instruments in relation to the patient’s anatomy to improve accuracy, which is vital in operations like Lindy’s where the spinal cord and vital organs might be only two or three millimetres away,” he said.
“It means less time under anaesthetic, fewer x-rays, smaller incisions and faster recovery.”
Following the success of her operation, another hospital in the Ramsay Health Care Group has also invested in the equipment.
Specialist spine surgeon Dr Jonathon Ball performed the first procedure in New South Wales at Sydney’s North Shore Private Hospital.
“This technology delivers unprecedented safety, reliability and accuracy for surgeons. I am now using it in almost every spinal fusion operation I perform,” Dr Ball said.
As chronic back pain affects nearly four million Australians, Ramsay hopes the two hospitals will attract patients from across the country seeking treatment via the new technology.
In alignment with the Federal Government’s mental health initiative the #SelfcareInHealthcare campaign has been launched to encourage Pharma, Biotech and MedTech industry professionals to take action on mental health during COVID-19. LinkedIn post.
News & Trends - Pharmaceuticals
Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
Obesity remains a pressing public health issue, serving as a key driver of numerous complications, including atherosclerotic cardiovascular disease (ASCVD) […]
MoreNews & Trends - MedTech & Diagnostics
‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
The private healthcare sector is grappling with escalating tensions between private hospitals and health insurers, with no resolution in sight. […]
MoreNews & Trends - Pharmaceuticals
BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
More